ExamPat
← Back to reexams

90/012,097Thin Film With Non-Self-Aggregating Uniform Heterogeneity and Drug Delivery Systems Made Therefrom7,425,292Closed

Status

Reexamination Certificate Issued

Filed

Jan 20, 2012

Last Updated

Jun 27, 2012

Art Unit

3991

Requester Law Firm

McCarter & English, LLP

Requested By

Third Party

Patent OwnerInferred

Monosolrx LLC

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

264Plastic And Nonmetallic Article Shaping Or Treating: Processes

Reexam History (30 events)

Sep 11, 2012N423Post Issue Communication - Certificate of Correction
Jun 27, 2012RXPTDIReexam Petition Decision - Dismissed
Jun 27, 2012REEXInput Issue Number and Issue Date for Reexamination
May 15, 2012RXPUBSReexam Forwarded to Office of Publications
May 4, 2012WIDSInformation Disclosure Statement (IDS) Filed
May 3, 2012PRXRParalegal Reexam Review Complete
Apr 24, 2012WIDSInformation Disclosure Statement (IDS) Filed
Apr 24, 2012RXSA..Supplemental Response after Non-Final Rejection
Apr 24, 2012RXC/SRCertificate of Service
Apr 23, 2012RXRLFReExam Litigation Found
Apr 23, 2012RXLITSRReexam Litigation Search Conducted
Apr 9, 2012RXPET.Receipt of Petition in a Reexam
Apr 9, 2012RXLET.Miscellaneous Incoming Letter
Apr 9, 2012RXC/SRCertificate of Service
Apr 9, 2012RXA...Response after Non-Final Action
Mar 27, 2012RXLET.Miscellaneous Incoming Letter
Mar 6, 2012NRX.Notice of Reexam Published in Official Gazette
Feb 1, 2012DOCKCase Docketed to Examiner in GAU
Jan 30, 2012RXWVSTWaiver of owners statement in ex parte
Jan 27, 2012RXNREQFDNotice of reexamination request filing date
Jan 27, 2012RXNREQAUNotice of assignment of reexamination request
Jan 27, 2012MRXNReexamination Formalities Notice Mailed
Jan 27, 2012MRXNReexamination Formalities Notice Mailed
Jan 26, 2012RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Jan 25, 2012RXTTLRPTTitle Report
Jan 22, 2012RXRLFReExam Litigation Found
Jan 22, 2012RXLITSRReexam Litigation Search Conducted
Jan 20, 2012RXOSUB.RReexamination requested by third party requester
Jan 20, 2012RXOSUBReceipt of Original Ex Parte Reexam Request
Jan 20, 2012RXIDS.Information Disclosure Statement Filed

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

IPR2013-00315IPR — Institution Denied

Petitioner

BioDelivery Sciences International, Inc.

Petition Filed

Jun 12, 2013

Institution

Nov 13, 2013

Terminated

Nov 13, 2013

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Sep 16, 2008
3.5-yr
Mar 16, 2012
7.5-yr
Mar 16, 2016
11.5-yr
Mar 16, 2020
Paid Mar 2, 2020
Expiry
Oct 28, 2023

Entity Status

Large Entity

Expires

Oct 28, 2023 (expired)

Term Adjustment

+621 days (~1.7 yr)

Assignments

20022003200420052006200720082009201020112012201320142015201620172018FiledJOSEPH M. FUISZRICHARD C. FUISZGARY L. MYERSROBERT K. YANGKOSMOS PHARMA LIMTIEDKOSMOS PHARMAMONOSOL RX, LLCMONOSOLRX, LLCPHILIP MORRIS USA INC.WHITE OAK GLOBAL ADVISORS, LLC, AS AGENTAQUESTIVE THERAPEUTICS, INC.PERCEPTIVE CREDIT HOLDINGS, LPMONOSOL RX LLCSecurity InterestWHITE OAK GLOBAL ADVISORS, LLCReleaseMONOSOL RX, INC.Security InterestAQUESTIVE THERAPEUTICS, INC.Security InterestPERCEPTIVE CREDIT HOLDINGS, LPReleaseAQUESTIVE THERAPEUTICS, INC.Security InterestU.S. BANK TRUST COMPANY NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S BANK NATIONAL ASSOCIATION)Release
AssignmentReel/Frame: 013002/0285Recorded: Jun 11, 2002

From

JOSEPH M. FUISZInventor
Apr 4, 2002
RICHARD C. FUISZInventor
Apr 4, 2002
GARY L. MYERSInventor
Apr 5, 2002
ROBERT K. YANGInventor
Apr 5, 2002
→

To

KOSMOS PHARMA

AssignmentReel/Frame: 014315/0613Recorded: Feb 6, 2004

From

KOSMOS PHARMA LIMTIED
Jan 23, 2004
→

To

MONOSOL RX, LLC

OtherReel/Frame: 019537/0247Recorded: Jul 10, 2007

From

MONOSOL RX, LLC
Jul 9, 2007
→

To

MONOSOLRX, LLC

Security InterestReel/Frame: 020797/0799Recorded: Apr 11, 2008

From

MONOSOL RX LLC
Apr 1, 2008
→

To

WHITE OAK GLOBAL ADVISORS, LLC, AS AGENT

OtherReel/Frame: 021861/0094Recorded: Nov 10, 2008

From

MONOSOL RX, LLC
Oct 18, 2008
→

To

PHILIP MORRIS USA INC.

OtherReel/Frame: 029490/0156Recorded: Dec 18, 2012

From

MONOSOL RX, LLC
Dec 6, 2012
→

To

WHITE OAK GLOBAL ADVISORS, LLC, AS AGENT

ReleaseReel/Frame: 039774/0782Recorded: Aug 22, 2016

From

WHITE OAK GLOBAL ADVISORS, LLC
Aug 16, 2016
→

To

MONOSOL RX, LLC

Security InterestReel/Frame: 039707/0194Recorded: Aug 16, 2016

From

MONOSOL RX, INC.
Aug 16, 2016
MONOSOL RX, LLC
Aug 16, 2016
MSRX US, LLC
Aug 16, 2016
→

To

PERCEPTIVE CREDIT HOLDINGS, LP

Name ChangeReel/Frame: 045196/0389Recorded: Jan 29, 2018

From

MONOSOL RX, LLC
Dec 29, 2017
→

To

AQUESTIVE THERAPEUTICS, INC.

OtherReel/Frame: 045279/0802Recorded: Jan 30, 2018

From

AQUESTIVE THERAPEUTICS, INC.
Jan 30, 2018
→

To

PERCEPTIVE CREDIT HOLDINGS, LP

Security InterestReel/Frame: 049758/0082Recorded: Jul 15, 2019

From

AQUESTIVE THERAPEUTICS, INC.
Jul 15, 2019
→

To

U.S. BANK NATIONAL ASSOCIATION

ReleaseReel/Frame: 049757/0733Recorded: Jul 15, 2019

From

PERCEPTIVE CREDIT HOLDINGS, LP
Jul 15, 2019
→

To

AQUESTIVE THERAPEUTICS, INC.

Security InterestReel/Frame: 065446/0494Recorded: Nov 2, 2023

From

AQUESTIVE THERAPEUTICS, INC.
Nov 1, 2023
→

To

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION

ReleaseReel/Frame: 065426/0642Recorded: Nov 1, 2023

From

U.S. BANK TRUST COMPANY NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S BANK NATIONAL ASSOCIATION)
Nov 1, 2023
→

To

AQUESTIVE THERAPEUTICS, INC.